Table 2. Baseline Urinary Isolates and Their Susceptibilities by Treatment Allocation.
No. (%) | ||
---|---|---|
Nitrofurantoin (n = 255) |
Fosfomycin (n = 258) |
|
Baseline cultures obtained | 243 (95) | 244 (95) |
Positive culturesa | 194 (80) | 183 (75) |
Escherichia colib | 111 (57) | 119 (65) |
Nitrofurantoin resistant | 2 (1) | 4 (3) |
Fosfomycin resistant | 0 (0) | 1 (1) |
Co-trimoxazole resistant | 26 (23) | 25 (21) |
Fluoroquinolone resistant | 13 (12) | 14 (12) |
Extended-spectrum beta-lactamase | 7 (6) | 2 (1) |
Klebsiella sppb | 20 (10) | 7 (4) |
Nitrofurantoin resistant | 3 (15) | 0 (0) |
Fosfomycin resistant | 2 (10) | 0 (0) |
Co-trimoxazole resistant | 4 (20) | 2 (29) |
Fluoroquinolone resistant | 1 (5) | 1 (14) |
Extended-spectrum beta-lactamase | 2 (10) | 1 (14) |
Proteus sppb | 7 (4) | 10 (5) |
Nitrofurantoin resistant | 6 (86) | 9 (90) |
Fosfomycin resistant | 0 (0) | 2 (20) |
Co-trimoxazole resistant | 3 (42) | 2 (20) |
Fluoroquinolone resistant | 2 (29) | 0 (0) |
Extended-spectrum beta-lactamase | 0 (0) | 0 (0) |
Enterococcus sppb | 13 (7) | 14 (7) |
Group B Streptococcusb | 7 (4) | 6 (3) |
Enterobacter sppb | 5 (3) | 4 (2) |
Mixed florab | 51 (26) | 40 (21) |
Otherb,c | 10 (5) | 7 (4) |
Positive culture was defined as the growth of 103 colony-forming units/mL or more of at least 1 uropathogen; laboratory reporting of culture growth is described in detail in the eAppendix in Supplement 3. All patients were symptomatic at baseline, thus those with a positive culture had confirmed urinary tract infection. Patients with mixed flora at baseline could not be analyzed for microbiologic outcomes.
Some cultures had polymicrobial growth.
Citrobacter koseri, Morganella spp, Staphylococcus aureus, Staphylococcus saprophyticus, and Streptococcus anginosus.